Neuraltus Pharma Raises $17 Million
Neuraltus Pharmaceuticals Inc., a Menlo Park, Calif.-based developer of small-molecule drugs for neurodegenerative diseases, has raised $17 million in Series A funding. Backers include Latterell Venture Partners, VantagePoint Venture Partners and Adams Street Partners.
26 March 2009•4 mins read
